Wegener's granulomatosis: Anti-proteinase 3 antibodies are potent inductors of human endothelial cell signaling and leakage response

Journal of Experimental Medicine

Volumn 187, Issue 4, 1998, Pages 497-503

  Sibelius, Ulf ^a   Hattar, Katja ^a   Schenkel, Angelika ^a   Noll, Thomas ^a   Csernok, Elena ^b   Gross, Wolfgang Ludwig ^b   Mayet, Werner Johannes ^c   Piper, Hans Michael ^a   Seeger, Werner ^a   Grimminger, Friedrich ^a  

^a JUSTUS LIEBIG UNIVERSITY   (Germany)

^b UNIVERSITY OF LÜBECK   (Germany)

^c JOHANNES GUTENBERG UNIVERSITY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN; F ACTIN; IMMUNOGLOBULIN F(AB')2 FRAGMENT; IMMUNOGLOBULIN G1; INOSITOL PHOSPHATE; MESSENGER RNA; MONOCLONAL ANTIBODY; MYELOBLASTIN; NEUTROPHIL CYTOPLASMIC ANTIBODY; PHOSPHATIDYLINOSITIDE; PROSTACYCLIN; THROMBOCYTE ACTIVATING FACTOR; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; AUTOIMMUNE DISEASE; CONTROLLED STUDY; ENDOTHELIUM CELL; HUMAN; HUMAN CELL; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; SIGNAL TRANSDUCTION; UMBILICAL VEIN; VASCULITIS; WEGENER GRANULOMATOSIS;

ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; CELL COMMUNICATION; CELLS, CULTURED; E-SELECTIN; ENDOTHELIUM, VASCULAR; ENZYME-LINKED IMMUNOSORBENT ASSAY; HUMANS; MYELOBLASTIN; PHOSPHATIDYLINOSITOLS; PLATELET ACTIVATING FACTOR; POLYMERASE CHAIN REACTION; SERINE ENDOPEPTIDASES; SIGNAL TRANSDUCTION; TUMOR NECROSIS FACTOR-ALPHA; VASCULAR CELL ADHESION MOLECULE-1; WEGENER GRANULOMATOSIS;

EID: 0032536533     PISSN: 00221007     EISSN: None     Source Type: Journal    
DOI: 10.1084/jem.187.4.497     Document Type: Article

References (39)

1. Hagen, E., B.E.P.B. Bailleux, L.A. van Es, M.R. Daha, and F.J. van der Woude. 1993. Antineutrophil cytoplasmatic antibodies: a review of the antigens involved, the assays, and the clinical and possible pathogenetic consequences. Blood. 82: 1996-2002.
2. Kallenberg, C.J.M., E. Brouwer, A.H.L. Mulder, C.A. Stegmann, J.J. Weening, and J.W. Cohen Tervaert. 1995. ANCA-pathophysiology revisited. Clin. Exp. Immunol. 100:1-3.
3. Lüdemann, J., B. Utecht, and W.L. Gross. 1990. Anti-neutrophil cytoplasm antibodies in Wegener's granulomatosis recognize an elastinolytic enzyme. J. Exp. Med. 171:357-362.
4. Jenne, D.E., J. Tschopp, B. Utecht, and W.L. Gross. 1990. Wegener's autoantigen decoded. Nature. 346:520.
5. Falk, R.J., and J.C. Jennette. 1988. Anti-neutrophil cytoplasmatic autoantibodies with specificity for myeloperoxidase in patients with systemic vasculitis and idiopathic necrotizing and crescentic glomerulonephritis. N. Engl. J. Med. 318:1651-1657.
6. Falk, R.J., R.S. Terrell, L.A. Charles, and J. Charles Jennette. 1990. Anti-neutrophil cytoplasmatic autoantibodies induce neutrophils to degranulate and produce oxygen radicals in vitro. Proc. Natl. Acad. Sci. USA. 87:4115-4119.
7. Van der Woude, F.J., S. Lobatto, H. Permin, M. van der Giessen, N. Rasmussen, A. Wiik, L.A. van Es, and G.K. van der Hem. 1985. Autoantibodies against neutrophils and monocytes: tool for diagnosis and marker of disease activity in Wegener's granulomatosis. Lancet. 1:425-129.
8. Nölle, B., U. Specks, J. Lüdemann, M.S. Rohrbach, R.A. DeRemee, and W.L. Gross. 1989. Anticytoplasmatic autoantibodies: their immunodiagnostic value in Wegener's granulomatosis. Ann. Intern. Med. 111:28-40.
9. Kain, R., K. Matsui, M. Exner, S. Binder, G. Schaffner, E.V. Sommer, and D. Kerjaschki. 1995. A novel class of autoantigens of anti-neutrophil cytoplasmic antibodies in necrotizing and crescentic glomerulonephrids: the lysosomal membrane glycoprotein h-lamp-2 in neutrophil granulocytes and a related membrane protein in glomerular endothelial cells. J. Exp. Med. 181:585-597.
10. Csernok, E., M. Ernst, W. Schmitt, D.F. Bainton, and W.L. Gross. 1994. Activated neutrophils express proteinase 3 on their plasma membrane in vitro and in vivo. Clin. Exp. Immunol. 95:244-250.
11. Csernok, E., J. Lüdemann, W.L. Gross, and D.F. Bainton. 1990. Ultrastructural localization of proteinase 3, the target antigen of anti-cytoplasmic antibodies circulating in Wegener's granulomatosis. Am. J. Pathol. 137:1113-1120.
12. Charles, L.A., M.L.R. Caldas, R.J. Falk, R.S. Terrell, and J.C. Jennette. 1991. Antibodies against granule proteins activate neutrophils in vitro. J. Leukocyte Biol. 50:539-546.
13. Mulder, A.H., J. Broekroelofs, G. Horst, P.C. Limburg, G.F. Nelis, and C.G. Kallenberg. 1994. Anti-neutrophil cytoplasmatic antibodies (ANCA) in inflammatory bowel disease: characterization and clinical correlates. Clin. Exp. Immunol. 95: 490-497.
14. Keogan, M.T., V.L. Esnault, A.J. Green, C.M. Lockwood, and D.L. Brown. 1992. Activation of normal neutrophils by anti-neutrophil cytoplasm antibodies. Clin. Exp. Immunol. 90: 228-234.
15. Mulder, A.H.L., F. Heeringa, E. Brouwer, P.C. Limburg, and C.G.M. Kallenberg. 1994. Activation of granulocytes by anti-neutrophil-cytoplasmatic antibodies (ANCA): a FcγRII-dependent process. Clin. Exp. Immunol. 98:270-278.
16. 4 generation. J. Exp. Med. 184:1367-1572.
17. Savage, C.O.S., B.E. Pottinger, G. Gaskin, C.D. Pusey, and J.D. Pearson. 1992. Autoantibodies developing to myeloperoxidase and proteinase 3 in systemic vasculitis stimulate neutrophil cytotoxicity towards cultured endothelial cells. Am. J. Pathol. 141:335-342.
18. Brouwer, E., M.G. Huitema, P.A. Klok, H. de Weerd, J.W. Cohen Tervaert, J.J. Weening, and C.G.M. Kallenberg. 1993. Antimyeloperoxidase-associated proliferarive glomerulonephritis: an animal model. J. Exp. Med. 177:905-914.
19. Mayet, W.J., A. Schwarting, and K.H. Meyer zum Büschenfelde. Cytotoxic effects of antibodies to proteinase 3 (C-ANCA) on human endothelial cells. Clin. Exp. Immunol. 97:458-465.
20. Mayet, W.J., E. Csernok, C. Szymkowiak, W.L. Gross, and K.H. Meyer zum Büschenfelde. 1993. Human endothelial cells express proteinase 3, the target antigen of anticytoplasmatic antibodies in Wegener's granulomatosis. Blood. 82:1221-1229.
21. Mayet, W.J., and K.H. Meyer zum Büschenfelde. 1993. Antibodies to proteinase 3 increase adhesion of neutrophils to human endothelial cells. Clin. Exp. Immunol. 94:440-446.
22. Mayet, W.J., A. Schwarting, T. Orth, R. Duchmann, and K.H. Meyer zum Büschenfelde. 1996. Antibodies to proteinase 3 mediate expression of vascular cell adhesion molecule-1 (VCAM-1). Clin. Exp. Immunol. 103:259-267.
23. Jaffe, E.A., R.L. Nachmann, and C.G. Becker. 1973. Culture of human endothelial cells derived from umbilical veins: identification by morphological criteria. J. Clin. Invest. 52:2745-2750.
24. Thornton, S.C., S.N. Mueller, and E.M. Levine. 1983. Human endothelial cells: use of heparin in cloning and long-term serial cultivation. Science. 222:623-625.
25. Noll, T., A. Muhs, M. Besselmann, H. Watanabe, and M. Piper. 1995. Initiation of hyperpermeability in energy-depleted coronary endothelial monolayers. Am. J. Physiol. 268:H1462-H1470.
26. Grimminger, F., U. Sibelius, S. Bhakdi, N. Suttorp, and W. Seeger. 1991. Echerichia coli hemolysin is a potent inductor of phosphoinositide hydrolysis and related metabolic responses in human neutrophils. J. Clin. Invest. 88:1531-1539.
27. Berridge, M.J., R.M.C. Dawson, C.P. Downes, J.P. Heslop, and R.F. Irvine. 1983. Changes in levels of mositol phosphates after agonist-dependent hydrolysis of membrane phosphoinositides. Biochem. J. 212:473-482.
28. Krämer, H.J., J. Stevens, and W. Seeger. 1993. Analysis of 2- and 3-series prostanoids by post-HPLC ELISA. Anal. Biochem. 214:535-543.
29. Aktories, K., M. Bärmann, I. Ohisi, S. Tsukayama, K.H. Jakobs, and E. Habermann. 1986. Botulinum C2 toxin ADP-ribosylates actin. Nature. 322:390-392.
30. Pötzsch, B., B. Kropp, H. Hausbruck, and G. Mueller-Berghaus. 1997. Detection of circulating thrombin-thrombomodulin complexes in human plasma. Ann. Hematol. 74:366.
31. Horvat, R., and G.E. Palade. 1993. Thrombomodulin and thrombin localization on the vascular endothelium; their internalization and transcytosis by plasmalemmal vesicles. Eur. J. Cell Biol. 61:299-313.
32. Bailleux, P.E.P.B., K.T. Zondervan, P. Kievit, C. Hagen, L.A. van Es, F.J. van der Woude, and M.R. Daha. 1994. Binding of proteinase 3 and myeloperoxidase to endothelial cells: ANCA-mediated endothelial damage through ADCC? Clin. Exp. Immunol. 97:52-60.
33. Carvallho, D., C.O.S. Savage, C.M. Black, and J.D. Pearson. 1996. IgG Antiendothelial cell autoantibodies from Scleroderma patients induce leukocyte adhesion to human vascular endothelial cells. J. Clin. Invest. 97:111-119.
34. Simantov, R., J.M. LaSala, S.K. Lo, A.E. Gharavi, L.R. Sammantano, J.E. Salmon, and R.L. Silverstein. 1995. Activation of cultured vascular endothelial cells by antiphospholipid antibodies. J. Clin. Invest. 96:2211-2219.
35. Davies, M.G., and P.O. Hagen. 1993. The vascular endothelium: a new horizon. Ann. Surg. 218:593-609.
36. Grimminger, F., U. Sibelius, K. Aktories, I. Just, and W. Seeger. 1991. Suppression of cytoskeletal rearrangement in activated human neutrophils by Botulinum C2 toxin. J. Biol. Chem. 226:19276-19282.
37. 2+ and inositol-polyphosphates. Am. J. Physiol. 263:L219-L225.
38. Gross, W.L., E. Csernok, and B.K. Flesch. 1993. 'Classic' anti-neutrophil cytoplasmatic autoantibodies (cANCA), 'Wegener's autoantigen' and their immunopathogenic role in Wegener's granulomatosis. J. Autoimmun. 6:171-184.
39. Ewert, H.B., J.C. Jennette, and R.J. Falk. 1991. The pathogenic role of antineutrophil cytoplasmatic autoantibodies. Am. J. Kidney Dis. 18:188-195.